Methods and compositions for ocular cell therapy
US-2023348852-A1 · Nov 2, 2023 · US
This page is not indexed by search engines while we improve data quality.
Berenshteyn Frada patents
Berenshteyn Frada is listed as an inventor on 5 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Berenshteyn Frada |
| Total patents | 5 |
| First publication | Dec 6, 2018 |
| Latest publication | Nov 2, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors
US-2023190751-A1 · Jun 22, 2023 · US
6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors
US-11458138-B2 · Oct 4, 2022 · US
Methods and compositions for ocular cell therapy
US-2020131474-A1 · Apr 30, 2020 · US
6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors
US-2018344738-A1 · Dec 6, 2018 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novartis Ag | 5 |
| Intellia Therapeutics Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/20 | 5 |
| C12N2502/085 | 5 |
| A61K35/30 | 5 |
| C12N5/0621 | 5 |
| A61P27/02 | 5 |